High-dose systemic iron chelation attenuates reperfusion injury.
Hedlund
B E
BE
Biomedical Frontiers, Inc., Minneapolis, MN 55414.
Hallaway
P E
PE
D000818:Animals; D003676:Deferoxamine / Q000627:therapeutic use; D004285:Dogs; D007501:Iron / Q000378:metabolism; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism; D051381:Rats
D007502:Iron Chelating Agents; D007501:Iron; D003676:Deferoxamine